Prandin Side Effects
Serious Side Effects of Prandin
- low blood sugar (hypoglycemia) with symptoms of feeling faint, dizzy, shaky, or anxious, loss of strength, loss of muscle control, mood or behavioral changes, persistent headache, numbness of the mouth and paleness of skin
- severe low blood sugar symptoms: feeling confused, passing out or having seizures (convulsions)
- high blood sugar (hyperglycemia) symptoms such as dryness of the mouth, stomach ache, throwing up, trouble breathing or suppression of breath, fruit-like odor of the breath, and difficulty concentrating
- feeling extremely thirsty or hungry
- urinating more often
- loss of muscle strength
- changes in vision such as blurry vision
Common Side Effects of Prandin
- headache
- stuffy nose
- aching or cramping of joints
- back pain
- bowel changes such as diarrhea or constipation
Warnings & Recalls for Prandin
Prandin and Pregnancy
Prandin is listed as an
FDA pregnancy Category C drug. Sufficient research of the effects of Prandin in pregnant women
has not been conducted to determine if Prandin
may harm the fetus. It is
unknown if Prandin may pass through breast milk or harm a nursing baby. Patients
should not take Prandin while breastfeeding. Talk to your doctor
before using Prandin if you are
pregnant,
may become pregnant or are
breastfeeding.
General Warnings
Prandin
is not for everyone. Prandin should not be taken by patients who:
- are allergic to Prandin
- have type 1 diabetes
- are suffering from ketoacidosis
Before taking Prandin
tell your doctor about any of the following you may have:
- liver disease
- kidney disease
- type 1 diabetes mellitus
- any allergies you may have
To avoid unwanted
interactions, let your healthcare provider know about all medicines you may be taking. Prandin
should not be used with
pioglitazone (Actos),
gemfibrozil, or
NPH insulin. The following may also interact with Prandin:
- medicines that raise blood sugar including isoniazid, diuretics, steroid medicines, phenothiazines, thyroid treatments, hormonal pills (including contraceptives), seizure medications, dieting pills, and drugs for treating breathing conditions or allergies.
- drugs that lower blood sugar levels such as probenecid, nonsteroidal anti-inflammatory drugs (NSAIDs), blood thinners, anti-inflammatory medicines, MOA inhibitors (monoamine oxidase inhibitor), antibacterial sulfonamides medicines, or any other medicines used for treating diabetes
- medicines for preventing transplant rejection
- drugs given after blood transfusion treatments to decrease iron levels
- St. John's wort
- antibiotics and anti-fungals
- narcotics
- drugs for treating heart disorders or blood pressure irregularities
- HIV or AIDS treatments
Alcohol may interact with Prandin and should be avoided for treatment to be effective.
Prandin Treatment and Use
Prandin | Repaglinide is a blood glucose-lowering (meglitinide) medicine marketed by Novo Nordisk for treating type 2 diabetes. Prandin may be use alone or along with other drugs such as metformin for reducing the risk of the following:
- kidney failure
- heart disease
- damage to the nervous system
- diabetes related impotence
Prandin is prescribed to patients who cannot lower their blood pressure through diet and exercise alone.
How Does Prandin Work?
Prandin works by assisting the pancreas in the process of creating more insulin after meals. By increasing insulin levels, blood sugar levels in the body are safely reduced and balanced.
Prandin Dosage Information
Prandin comes in tablet form to be taken orally. Swallow Prandin whole with a full glass of water. Prandin should be taken 30 minutes or less before a meal. Be sure to use Prandin any time you will be eating a meal. Prandin should not be taken without a meal. Use the dosage amount prescribed to you by your doctor. Follow all directions given by your healthcare provider regarding diet guidelines and exercise.
Your blood sugar levels should be checked on a regular basis while taking Prandin.
Other Names for Prandin
Brand name:
Generic name:
Lawsuits & Legal Information for Prandin
Author:
Lauren Cohrs
Posted on Jul 25, 2012